Contact
Please use this form to send email to PR contact of this press release:
Arcutis Announces Enrollment of First Patient in Phase 1/2b Study of ARQ-252 in Patients with Chronic Hand Eczema
TO:
Please use this form to send email to PR contact of this press release:
Arcutis Announces Enrollment of First Patient in Phase 1/2b Study of ARQ-252 in Patients with Chronic Hand Eczema
TO: